Results 91 to 100 of about 253,625 (250)
Clinical aspects of mCRPC management in patients treated with radium-223 [PDF]
, 2020 Bone is the most common site of metastasis in metastatic castration-resistant prostate cancer (mCRPC), which is associated with pain and skeletal events. Radium-223 dichloride (Xofigo) is an alpha-emitting radioactive isotope that can specifically target
Rizzini EL +5 more
core +1 more source
Nanomaterials, 2020 Barium ferrite nanoparticles (BaFeNPs) were investigated as vehicles for 223Ra radionuclide in targeted α-therapy. BaFe nanoparticles were labeled using a hydrothermal Ba2+ cations replacement by 223Ra with yield reaching 61.3 ± 1.8%.
Weronika Gawęda +8 more
doaj +1 more source
Utility of F-18 FDG PET/CT for Detection of Bone Marrow Metastases in Prostate Cancer Patients Treated with Radium-223 [PDF]
Asia Oceania Journal of Nuclear Medicine and Biology, 2018 A 76-year-old man with symptomatic bone metastases from castrationresistant prostate cancer underwent Radium-223-dichloride (Ra-223) therapy. Before Ra-223 therapy, he had normal peripheral blood cell counts.
Kaoru Maruyama +5 more
doaj +1 more source
Radium-223 and concomitant therapies: prospects and prudence [PDF]
Translational Andrology and Urology, 2016 Most patients with relapsed prostate cancer develop metastatic disease and eventually become castration-resistant. Skeletal metastasis is common in castrate resistant prostate cancer and is an independent poor prognostic factor (1). Furthermore, skeletal related events (SRE) such as spinal cord compression, pathologic fractures and requirement for ...
Yeku, Oladapo, Slovin, Susan F.
openaire +2 more sources
Rheumatology &Autoimmunity, EarlyView.This large‐scale retrospective study of 5778 primary Sjögren's disease (SjD) patients, stratified by diagnostic age, defines a distinct clinical and immunological profile for early‐diagnosed (<45 years) disease. We identified early diagnosis as an independent risk factor for hypergammaglobulinemia and interstitial lung disease, underpinned by a ...
Yuan Ning +7 more
wiley +1 more source
Radium-223 in mCPRC patients: a large real-life Italian multicenter study
, 2022 Background: Radium-223 is a targeted alpha-particles therapy approved for the treatment of mCRPC patients with symptomatic bone metastases. To our knowledge we account for the largest cohort of mCRPC patients subjected to Radium-223 treatment in our ...
Lavelli, Valentina +15 more
core +2 more sources
Nonthermal plasma approaches for combating implant‐associated infections: A compendious review
VIEW, EarlyView.Implant‐associated infections pose serious clinical challenges. Non‐thermal plasma (NTP) modifications overcome this bottleneck in distinct ways relative to traditional sterilization methods. Gas‐phase plasmas generate highly energetic species, UV radiation and reactive oxygen/nitrogen species (RONS), which alter the implant surface properties.
A. M. Trimukhe +8 more
wiley +1 more source
, 1915 Pamphlet published by the Radium Chemical Company, describing Radium Emanation Therapeutics, Radium Drinking Water, and Radium Bath Water.Dosages and directions for administering the drug orally and intravenously are included.Includes ...
Radium Chemical Company
core
Journal of Vinyl and Additive Technology, Volume 31, Issue 2, Page 339-355, March 2025.Effecft of co‐doping polyaniline with phosphoric acid and phytic acid on the heat release rate of polyethylene. Abstract Polyolefins, such as polyethylene (PE), are highly flammable and electrically insulative, limiting their applicability. The study explored the flame‐retardancy and electrical conductivity of PE/polyaniline (PE/PANI) nanocomposites ...
Akeem Adisa +4 more
wiley +1 more source
, 1915 Pamphlet published by the Radium Chemical Company, describing Radium Therapy, Radium Drinking Water, Radium Bath Water, and optimal the Radium syringes for injection.|The pamphlet also illustrates the products and the product packaging in color.Dosages
Radium Chemical Company
core